As an eligible individual pursuing an Ozempic gastroparesis claim, you have the right to seek compensation for both economic and non-economic losses
Ensuring clear safety disclosures, especially around compounded drugs Compounded drugs are custom medications prepared by a pharmacist for an individual patient, often when an FDA-approved product is not medically appropriate, or when the approved drug is in short supply and meets the conditions set out in federal law
Retatrutide remains in Phase 3 clinical trials with FDA approval expected around 2026-2027
doi:10.1080/08998280.2025.2456441
[12] The 520IU dose provides meaningful support without excessive intake that could lead to soft tissue calcification
Patients with contraindicationsincluding personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, or severe gastrointestinal diseaseshould not use GLP-1 medications